Issue link: https://www.e-digitaleditions.com/i/1482817
Firocoxib Tablets for Horses For complete prescribing information, see full package insert. Caution: Federal law restricts this drug to use by or on the order of a licensed veterinarian. It is a violation of Federal Law to use this product other than as directed in the labeling. Indication: for the control of pain and inflammation associated with osteoarthritis in horses. Warnings: For use in horses only. Do not use in horses intended for human consumption. Store tablets out of the reach of dogs and other pets in a secured location to prevent accidental ingestion or overdose. Not for human use. Keep out of reach of children. Contact a physician in case of accidental ingestion by humans. Contraindications: Firocoxib Tablets for Horses should not be used in animals with a history of hypersensitivity to firocoxib. Precautions: Horses should undergo a thorough history and physical examination before initiation of NSAID therapy Appropriate laboratory tests should be conducted to establish hematological and serum biochemical baseline data before and periodically during administration of any NSAID. Clients should be advised to observe for signs of potential drug toxicity. Treatment should be terminated if signs such as inappetence, colic, abnormal feces, or lethargy are observed. As a class, cyclooxygenase inhibitory NSAIDs may be associated with gastrointestinal, renal and hepatic toxicity. Patients at greatest risk for adverse events are those that are dehydrated, on diuretic therapy, or those with existing renal, cardiovascular, and/or hepatic dysfunction. Concurrent administration of potentially nephrotoxic drugs should be carefully approached or avoided. NSAIDs may inhibit the prostaglandins that maintain normal homeostatic function. Such anti-prostaglandins effects may result in clinically significant disease in patients with underlying or pre-existing disease that has not been previously diagnosed. Since many NSAIDs possess the potential to produce gastrointestinal ulcerations and/or gastrointestinal perforation, concomitant use of this product with other anti-inflammatory drugs should be avoided. The concomitant use of protein bound drugs with Firocoxib Tablets for Horses has not been studied in horses. The influence of concomitant drugs that may inhibit the metabolism of Firocoxib Tablets for Horses has not been evaluated. Drug compatibility should be monitored in patients requiring adjunctive therapy. The safe use of Firocoxib Tablets for Horses in horses less than one year in age, horses used for breeding, or in pregnant or lactating mares has not been evaluated. Consider appropriate washout times when switching from one NSAID to another NSAID or corticosteroid. To obtain full product information, request a Safety Data Sheet, or report suspected adverse events, please call 800-874-9764. Approved by FDA under ANADA # 200-726 Pegasus Laboratories, Inc. Sē●Qual™ Products Dosage and Administration: For oral use in horses only. The total recommended daily dosage range for Firocoxib Tablets for Horses is one 57 mg tablet for up to 14 days, dosed with or without food. Storage: Store at 20-25°C (68-77°F).